Position in DHR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$443,246
-$6,093,155 QoQ
Shares Held
2,327
-93.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,421
of 2,098 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quadrature Capital Ltd holds $68,972,151 across 20 Diagnostics & Research names. DHR ranks #15 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
79,969 | $21,707,585 | |
| 2 | GH |
Guardant Health, Inc.
|
63,165 | $9,476,644 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
6,137 | $7,840,078 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
15,383 | $7,712,420 | |
| 5 | RVTY |
Revvity, Inc.
|
48,540 | $5,400,560 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
7,697 | $4,076,254 | |
| 7 | TWST |
Twist Bioscience Corp
|
33,930 | $3,490,718 | |
| 8 | ICLR |
Icon PLC
|
13,531 | $2,350,470 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $443,246 | 2,327 | Shares | Other | 2026-08-07 | |
| 2025-06-30 | $6,536,401 | 33,089 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,251,045 | 40,249 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $9,884,193 | 43,059 | Shares | Other | 2025-02-13 | |
| 2023-06-30 | $11,495,762 | 47,899 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,947,829 | 63,275 | Shares | Sole | 2023-05-15 | |
| 2021-12-31 | $973,869 | 2,960 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $4,320,635 | 19,196 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,822,288 | 12,705 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $599,176 | 4,329 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||